Chronic cisplatin treatment (11.8 μM) promoted intratumoral T-cell accumulation and advanced tumor immunogenicity through the cGAS-STING pathway in an epithelial ovarian cancer mouse model [128]. This evidence concerns the gene STING1 and neoplasm.